课题基金 / 基金详情

Clinical Trial Operations Core

Clinical Trial Operations Core
临床试验运营核心
批准号:
10705233
负责人:
Annick Desjardins
金额:
$26.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-24 至 2024-08-31
关键词:
AntigensAvastinBioinformaticsBiometryBone MarrowBrainBrain NeoplasmsCancer VaccinesCase Report FormCertificationClinicClinicalClinical DataClinical ManagementClinical ResearchClinical TrialsClinical Trials DesignCollaborationsCollectionConduct Clinical TrialsConflict of InterestConsentDatabasesDedicationsDevelopmentDoctor of MedicineDoctor of PhilosophyDocumentationElectronicsEnrollmentEnsureEvaluationFamilyFederal GovernmentGliadelGlioblastomaGliomaGoalsHealth systemImmuneImmunologic MonitoringIndividualInfrastructureInterdisciplinary CommunicationInternationalInvestigationLaboratoriesLaboratory FindingLeadershipMGMT geneMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of brainManuscriptsMethodologyMutateNewly DiagnosedPathologyPatient RecruitmentsPatient-Focused OutcomesPatientsPopulation HeterogeneityPreparationPrimary Brain NeoplasmsProceduresProcessProtocols documentationPublicationsRegulatory T-LymphocyteResearchResearch DesignResearch SupportSafetyServicesSpecialistT-LymphocyteTherapeutic Clinical TrialTissuesTrainingTranslatingTranslational ResearchUnited States Food and Drug AdministrationUniversitiesbiobankcareerclinical materialcost effectivedata acquisitiondata managementelectronic datafollow-upimprovedinnovationinterdisciplinary collaborationmeetingsmonocytemultidisciplinaryneoantigen vaccineneuro-oncologyoperationparticipant enrollmentpatient populationprogramspromoterprotocol developmentquality assurancerecruitscreeningtemozolomidetranslational goalvaccine strategy

项目摘要

项目成果

Annick Desjardins的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT – Clinical Trial Operations Core (Core 2) The Clinical Trial Operations Core provides critical research support to promote seamless and efficient development, recruitment and conduct of the clinical trials in the Duke Brain SPORE's three projects and clinical studies proposed by Developmental and Career Enhancement awardees. Bringing strong expertise in neuro-oncology and clinical trial operations to the SPORE, the Core ensures the safe and efficient conduct of clinical studies (Aim 1) and recruitment, consent and enrollment of a diverse group of subjects for biospecimen collection and clinical studies (Aim 2). Through these Aims, the Core provides critical oversight of the full range of clinical trial activities, including study design, protocol preparation, research staff training, patient recruitment, patient evaluation during treatment and follow-up, assessment and treatment of complications, and evaluation of patient outcomes. To ensure rigorus trial conduct, the Core mainatins a full portfolio of standard operating procedures (SOPs). In addition, the Core is fully integrated with other Duke Brain SPORE components to ensure seamless research coordination. For example, in partnership with the Administrative Core, this Clinical Trial Operations Core provides regulatory specialists to meet the requirements of the federal government, Duke University Health System (DUHS), and Duke Cancer Institute (DCI) and avoid conflict of interest (COI). This Core also collaborates with the Biostatistics and Bioinformatics Core (Core 1) in the development of the protocol electronic case report forms (eCRFs), study database, data management, quality assurance, and summarization of clinical data for presentation at international meetings and manuscript publications. Finally, the Clinial Trial Operations Core supplies electronic data acquisition and documentation services for the Biostatistics and Bioinformatics Core (Core 1) and facilitates tissue biobanking with the Biospecimen and Immune Monitoring Core (Core 3). By enchancing interdisciplinary communictation and collaboration in this way, the Core supports the the SPORE's commitment to both translate laboratory findings to the clinic and collect clinical material to be studied in the laboratory.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 1: Targeting cytomegalovirus antigens in glioblastoma with regulatory T cell depletion
  • 批准号:
    10477338
  • 项目类别:
  • 资助金额:
    $56.43万
  • 财政年份:
    2018
  • 负责人:
    Annick Desjardins
  • 依托单位:
Clinical Trials and Imaging Core
  • 批准号:
    10477343
  • 项目类别:
  • 资助金额:
    $22.9万
  • 财政年份:
    2018
  • 负责人:
    Annick Desjardins
  • 依托单位:
Clinical Trials and Imaging Core
  • 批准号:
    10006182
  • 项目类别:
  • 资助金额:
    $21.62万
  • 财政年份:
    2018
  • 负责人:
    Annick Desjardins
  • 依托单位:
Clinical Trials and Imaging Core
  • 批准号:
    10246891
  • 项目类别:
  • 资助金额:
    $23.05万
  • 财政年份:
    2018
  • 负责人:
    Annick Desjardins
  • 依托单位:
海外基金